Cell therapy

CAR-T cells attack cancer cells
#Cancer research #CAR-T #Cell and gene therapy #Cell therapy #High throughput screening #Immunotherapy #T cell activation

Watch now: Improve cell therapies with high-throughput CAR libraries

CAR-T cell therapies are a promising approach for treating solid tumours. But identifying appropriate T-cell receptor (TCR) domains that exclusively target tumour antigens remains a challenge. Toxicity, tumour activation, and tumour persistence are significant challenges to using CAR-T cell therapies for solid tumours. In this new on-demand… Read More

Webinar date:
Brought to you by Twist Bioscience
#Editor's Choice #News

CAR-T cells attack cancer cells
#Cancer research #CAR-T #Cell and gene therapy #Cell therapy #High throughput screening #Immunotherapy #T cell activation

Improving cell therapies with high-throughput CAR libraries

CAR-T cell therapies are a promising approach for treating solid tumours. But identifying appropriate T-cell receptor (TCR) domains that exclusively target tumour antigens remains a challenge. Toxicity, tumour activation, and tumour persistence are significant challenges to using CAR-T cell therapies for solid tumours. In this webinar, Twist Bioscience’s CSO, Aaron… Read More

Webinar date:
Brought to you by Twist Bioscience
#Webinars

Multiple myeloma
#Arcellx #Cancer research #Cell therapy #Collaboration #Kite #Myeloma #Partnership #T cell activation

Partnership will co-develop cell therapy for multiple myeloma

Kite and Arcellx have entered a global strategic collaboration to co-develop and co-commercialise CART-ddBCMA for the treatment of patients with relapsed or refractory multiple myeloma.  Currently in Phase II clinical development, CART-ddBCMA is an investigational cell therapy product comprising autologous T cells that have been genetically modified… Read More

#Cancer Research #News

Cell culture media
#Biologics #Bioproduction #Cell and gene therapy #Cell therapy #Life sciences #Manufacturing

Fujifilm expands cell culture media manufacturing

Fujifilm Corporation has announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA.  The new site will be operated by Fujifilm Irvine Scientific, a manufacturer of cell culture solutions for life science research, bioproduction, cell therapy… Read More

#News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

Five key news stories available on DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week started with World Diabetes Day on 14 November and concluded… Read More

#News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

This week in drug discovery (14-18 November)

News round-up for 14-18 November by DDW Digital Content Editor Diana Spencer.  This week started with World Diabetes Day on 14 November and concluded with the start of World Antimicrobial Awareness Week, which aims to improve education and understanding of the growing issue of antimicrobial resistance. … Read More

#News

T cells attacking cancer
#Cancer #Cancer immunotherapy #Cell and gene therapy #Cell therapy #HER2 #Immunotherapy #Oncology #Precision medicine #T-Cells #Tumours

Positive interim data for cell therapy in solid tumours

Triumvira Immunologics has revealed positive clinical data from its ongoing TACTIC‑2 Phase I/II trial of TAC01-HER2 in patients with human epidermal growth factor receptor 2 (HER2) positive solid tumours.  These interim data demonstrate that TAC01-HER2 is well-tolerated and clinical activity was observed in the two higher dosing cohorts,… Read More

#Cancer Research #News

#Advanced Therapies Europe #CAR-T #Cell and gene therapy #Cell therapy #Collaboration

On the European CGT landscape, zebras and the future of medicine

Listen to this article on the DDW podcast: Alongside industry professionals interested in the cell and gene therapy landscape in Europe, DDW’s Multimedia Editor Megan Thomas was welcomed to Advanced Therapies Europe 2022 by Phacilitate’s Vice President, Becky Johnson-Kent. Johnson-Kent introduced the notion of the zebra company and compared its two-fold… Read More

#Editor's Choice #Exclusive Content

Tomi Kalpio
#Bioprinting #Cell therapy #Organ manufacturing #Start-ups #Tissue engineering

A personal touch: the role of bioprinting in drug discovery

Listen to this article on the DDW podcast: DDW Editor, Reece Armstrong, sits down with Brinter CEO Tomi Kalpio to learn about the company’s approach to bioprinting and how it can be used throughout drug discovery.  Brinter is a provider of 3D bioprinting solutions based in Turku, Finland and the US. Read More

#Exclusive Content #Start-up Zone

Cell therapy platform
#Automation / robotics #Biotechnology #Cell and gene therapy #Cell therapy

Platform enables cell therapy commercialisation

Terumo Blood and Cell Technologies (BCT) has launched the Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the cell and gene therapy (CGT) sector.   Responding to the industry’s need for earlier automation to potentially limit additional and… Read More

#News

#Automation / robotics #Biotechnology #Cell therapy #Novel candidates

Ori Biotech and CTMC accelerate novel cell therapy delivery 

Ori Biotech and the Cell Therapy Manufacturing Center (CTMC) have partnered to accelerate process development, clinical implementation, and commercialisation of novel cell therapies.   The partnership will combine Ori’s technology platform with CTMC’s manufacturing capabilities and, in the first instance, will focus on a cell therapy invented by Dr Sattva Neelapu,… Read More

#Business & Investment #News

#Cell therapy #Flow Cytometry #Immunogenicity #Podcast #Technology #Therapeutics

New podcast: Revealing the magic of cell therapy

This is the latest episode of the free DDW podcast, “Revealing the magic of cell therapy”. It covers two narrated articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “The magic of cell therapy” and “Cellular assays to bridge the gap… Read More

#News

#Biomanufacturing #Cell and Gene Therapy Catapult #Cell therapy #Manufacturing

UK consortium looks to advance cell therapy manufacturing  

A new consortium has been launched in the UK to help drive innovation in the manufacturing of personalised cell therapies.  The consortium was launched by the Cell and Gene Therapy Catapult (CGT Catapult) and will be led by advanced therapy medicinal products (ATMP) developer Achilles Therapeutics. The… Read More

#News

#Animal models #Cell therapy #Humanised Immune System (HIS) #Immunotherapy

Mice with humanised immune systems advance cell-based immunotherapy

Listen to this article on the DDW Podcast: By Courtney Ferrebee, PhD, Field Applications Scientist, Taconic Biosciences. Although immunotherapy has revolutionised cancer therapy, the effectiveness of currently available immunotherapies varies significantly across patients and treatment types. As a result, researchers are striving to continually improve immuno-oncology approaches using the patient's own… Read More

#Exclusive Content

#Biotechnology #Cell therapy #Narrated podcasts #Oncology

The pursuit of better cancer treatments

This is the latest episode of the free narrated DDW podcast, “The pursuit of better cancer treatments”. It covers two narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. They are called “The personal touch: the scientist making an impact in cancer research” and… Read More

#Podcasts

#Biopharma #CAR-T #Cell therapy

Kite releases long-term data for cell therapy  

Biopharmaceutical company Kite has announced long-term follow up results of two studies for its CAR T-cell therapy Tecartus (brexucabtagene autoleucel). The results of both a three- and two-year follow-up of the company’s ZUMA trial were announced at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. … Read More

#News